FMC Corp 1Q 2026: Revenue $758.6M, EPS ($2.25) — 10-Q Summary

FMC Corp reported first-quarter 2026 results with revenue of $758.6M, down from $791.4M a year earlier, and a net loss attributable to FMC stockholders of $281.3M, or diluted loss per share of ($2.25), versus a loss of $15.5M, or ($0.12) in the prior-year quarter.Financial HighlightsMetricCurrent quarterPrior year quarterYoY changeRevenue¹$758.6M$791.4M(4.1%)Net income²($281.3M)($15.5M)(1714.8%)Diluted EPS³($2.25)($0.12)(1775%)¹ Reported as “Revenue”. ² Reported as “Net income (loss) attributable to FMC stockholders”. ³ Reported as “Diluted earnings (loss) per common share attributable to FMC stockholders”.Business HighlightsRevenue declined about 4% year-over-year, with pricing pressure offsetting volume gains in EMEA and North America.Regional performance: EMEA grew ~13% driven by volume, North America rose ~6%, while Latin America and Asia fell, with Asia down about 39%.Branded herbicides and Cyazypyr® showed momentum; the company is managing a post-patent transition for Rynaxypyr® and advancing new active ingredients.FMC classified its India commercial business as held for sale, planning a supply agreement while manufacturing remains in India.Launched Project Foundation, a multi-year cost optimization and restructuring program including asset exits and operational reshaping.Original SEC Filing: FMC CORP [ FMC ] - 10-Q - Apr. 30, 2026DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.